Epigenetic priming promotes acquisition of TKI resistance and oncogene amplification in human lung cancer
This study examined oncogene amplification in the context of acquired osimertinib-resistance. Whole genome sequencing was performed in paired parental and osimertinib-resistant EGFR-mutant lung adenocarcinoma cell lines.